
    
      Primary Objective: To estimate progression-free survival rates.

      Secondary Objectives

        -  To obtain information concerning the feasibility of administration of the proposed
           treatment, including patient participation in trials using the proposed treatment.

        -  To evaluate safety and tolerability in this patient population.

        -  To evaluate the effect on levels of alpha-fetoprotein.
    
  